Cetirizine Dosing for a 6 kg Child
For a 6 kg infant, cetirizine should be dosed at 0.25 mg/kg twice daily, which equals 1.5 mg twice daily (3 mg total per day).
Dosing Rationale
The evidence strongly supports weight-based dosing for young children rather than fixed doses. Based on the FDA label and clinical research:
- Standard pediatric dose: 0.25 mg/kg twice daily 1, 2, 3, 4
- For a 6 kg child: 1.5 mg per dose, given twice daily
- Total daily dose: 3 mg/day
This dosing has been extensively validated in infants as young as 6 months of age in multiple prospective studies 2, 3.
Evidence Quality
The 0.25 mg/kg twice daily regimen is supported by:
- Long-term safety data: The ETAC study followed 817 children aged 12-24 months for 18 months using this exact dose, demonstrating excellent safety with no clinically relevant adverse effects 2
- Pharmacokinetic validation: Studies in infants 6-11 months confirmed appropriate drug levels and 87-90% histamine inhibition at 12 hours post-dose with this regimen 3, 4
- Recent modeling: 2026 PBPK modeling confirmed 0.25 mg/kg BID as optimal for children under 6 years 5
Practical Administration
Since cetirizine oral solution typically comes as 1 mg/mL (5 mg/5 mL):
- Give 1.5 mL twice daily for a 6 kg child
- Administer approximately 12 hours apart
- Can be given with or without food
Safety Profile
Cetirizine is well-tolerated in infants 2, 3:
- No cardiac effects (no QTc prolongation documented)
- No developmental concerns in long-term studies
- Most common side effect: mild somnolence (though often less than placebo in some studies)
- No dose adjustment needed for short-term use in otherwise healthy infants
Important Caveats
- Age consideration: While studied down to 6 months, use in younger infants requires careful consideration
- Renal/hepatic impairment: Dose reduction may be needed (consult specialist)
- Duration: The twice-daily regimen provides more consistent coverage than once-daily dosing in this age group due to faster clearance 4
The FDA label 1 recommends "ask a doctor" for children under 6 years, but extensive clinical trial data supports the 0.25 mg/kg BID dosing as both safe and effective for infants meeting age criteria 2, 3, 6.